|Bid||9.84 x 0|
|Ask||9.85 x 0|
|Day's Range||9.40 - 9.87|
|52 Week Range||4.93 - 26.79|
|Beta (5Y Monthly)||3.16|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 12, 2021 - May 17, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||12.79|
Jim Carroll, Students Against Destructive Decisions Senior Advisor, joins Yahoo Finance’s Adriana Belmonte, Kristin Myers and Alexis Christoforous to discuss surge in overdose deaths amid the pandemic and drug prevention.
Top marijuana stocks fell further after Aphria reported results that missed expectations as coronavirus lockdowns hit sales.
In 11:30 a.m. EDT trading, Canopy Growth (NASDAQ: CGC) stock is down a depressing 4.4%, and cannabis rivals Aurora Cannabis (NYSE: ACB) and Hexo (NYSE: HEXO) have both tumbled about 8% each. Yes, unfair as it may feel, the stock to blame for Canopy's, Aurora's, and Hexo's declines today is none of the above, but rather their cannabis-growing rival Aphria, which reported its fiscal Q3 2021 earnings results this morning. Worse, Aphria reported a CA$1.14-per-share loss for the quarter, versus the tiny profit (calculated according to generally accepted accounting principles or GAAP) reported a year ago.